Hot Features
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The compa... EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.0002 | 0.0002 | 0.0002 | 51200 | 0.0002 | CS |
| 12 | -0.0523 | -99.619047619 | 0.0525 | 0.0915 | 0.0002 | 10906 | 0.01391524 | CS |
| 26 | -0.0809 | -99.7533908755 | 0.0811 | 0.0915 | 0.0002 | 7249 | 0.03220607 | CS |
| 52 | -0.0898 | -99.7777777778 | 0.09 | 0.1056 | 0.0002 | 5561 | 0.05538424 | CS |
| 156 | -0.7029 | -99.9715545442 | 0.7031 | 1.95 | 0.0002 | 3824 | 0.21745917 | CS |
| 260 | -3.9998 | -99.995 | 4 | 4.74 | 0.0002 | 3187 | 0.72436163 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.